Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “normal”

47 pharma patents match "normal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 47
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 47 pharmaceutical patents matching "normal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

47 results for “normal” · 30,257 patents in full index Clear search

  1. US 9675653

    Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

    YOUNG LIVING ESSENTIAL OILS, LC · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  2. US 9512191

    Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  3. US 9115150

    Camptothecin compound containing stable 7-membered lactone ring, preparation method and use

    EAST CHINA NORMAL UNIVERSITY · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  4. US 9066904

    Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

    YOUNG LIVING ESSENTIAL OILS, LC · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  5. US 8951794

    Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  6. US 8945858

    Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  7. US 8841266

    Pharmaceutical composition and method for regulating abnormal cellular proliferation

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  8. US 8722884

    Pyrimidine derivatives for the treatment of abnormal cell growth

    VERASTEM, INC. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  9. US 8389478

    Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted
  10. US 8329141

    Locoregional internal radionuclide ablation of abnormal tissues

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  11. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  12. US 8129334

    Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory

    The Regents of the University of California · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  13. US 7585852

    Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation

    Solidago AG · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted
  14. US 7531162

    Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation

    Regents of the University of Minnesota · Granted May 12, 2009 · Expires May 7, 2029

    granted
  15. US 7399827

    Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted
  16. US 6803359

    Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs

    The Regents of the University of California · Granted Oct 12, 2004 · Expires Oct 7, 2024

    expired
  17. US 6756210

    Linoleic acid diol and glucuronide conjugate levels as diagnostic markers of disorders of abnormal regulation of cytochrome P450 metabolism of unsaturated fatty acids

    The Regents of the University of California · Granted Jun 29, 2004 · Expires Jun 24, 2024

    expired
  18. US 6319900

    Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs

    The Regents of the University of California · Granted Nov 20, 2001 · Expires Nov 15, 2021

    expired
  19. US 6123941

    Method for restoration of normal phenotype in cancer cells

    The Regents of the University of California · Granted Sep 26, 2000 · Expires Sep 21, 2020

    expired
  20. US 6087110

    Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 11, 2000 · Expires Jul 6, 2020

    expired
  21. US 6043223

    Enhanced opening of abnormal brain tissue capillaries

    The Regents of the University of California · Granted Mar 28, 2000 · Expires Mar 23, 2020

    expired
  22. US 6034109

    Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia

    The Regents of the University of California · Granted Mar 7, 2000 · Expires Mar 2, 2020

    expired
  23. US 6028103

    Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation

    Ion Pharmaceuticals, Inc. · Granted Feb 22, 2000 · Expires Feb 17, 2020

    expired